Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
Signorelli F, Balbi GGM, Aikawa NE, Silva CA, Kupa LVK, Medeiros-Ribeiro AC, Yuki EF, Pasoto SG, Saad CG, Borba EF, Seguro LPC, Pedrosa T, Oliveira VAA, Costa ALCS, Ribeiro CT, Santos REB, Andrade DCO, Bonfá E. Signorelli F, et al. Among authors: andrade dco. Lupus. 2022 Jul;31(8):974-984. doi: 10.1177/09612033221102073. Epub 2022 May 20. Lupus. 2022. PMID: 35593174 Free PMC article.
Neurologic manifestations of antiphospholipid syndrome.
Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, de Souza AWS, Andrade D. Ricarte IF, et al. Lupus. 2018 Aug;27(9):1404-1414. doi: 10.1177/0961203318776110. Epub 2018 May 17. Lupus. 2018. PMID: 29768970 Review.
Anti-collagen type v: a marker of early systemic sclerosis?
Ugolini-Lopes MR, Mantovani E, Bonoldi VLN, de Medeiros Ribeiro AC, Bonfá E, Yoshinari N, Andrade D. Ugolini-Lopes MR, et al. Adv Rheumatol. 2019 May 14;59(1):19. doi: 10.1186/s42358-019-0063-y. Adv Rheumatol. 2019. PMID: 31088556
Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
Islabão AG, Mota LMH, Ribeiro MCM, Arabi TM, Cividatti GN, Queiroz LB, Andrade DC, Sakamoto AP, Trindade VC, Novak GV, Molinari BC, Campos LM, Aikawa NE, Pereira RMR, Terreri MT, Magalhães CS, Marini R, Gomes HR, Silva MF, Oliveira SK, Sztajnbok FR, Sacchetti SB, Bica BE, Sena EG, Moraes AP, Santos MC, Robazzi TC, Spelling PF, Scheibel IM, Cavalcanti AS, Naka EN, Guimarães LJ, Santos FP, Sampaio MC, Bonfá E, Silva CA; Brazilian Childhood-onset Systemic Lupus Erythematosus Group. Islabão AG, et al. Autoimmun Rev. 2020 Dec;19(12):102693. doi: 10.1016/j.autrev.2020.102693. Epub 2020 Oct 22. Autoimmun Rev. 2020. PMID: 33164791
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Wang X, Gkrouzman E, Andrade DCO, Andreoli L, Barbhaiya M, Belmont HM, Branch DW, de Jesús GR, Efthymiou M, Ríos-Garcés R, Gerosa M, El Hasbani G, Knight J, Meroni PL, Pazzola G, Petri M, Rand J, Salmon J, Tektonidou M, Tincani A, Uthman IW, Zuily S, Zuo Y, Lockshin M, Cohen H, Erkan D; APS ACTION. Wang X, et al. Among authors: andrade dco. Lupus. 2021 Dec;30(14):2276-2285. doi: 10.1177/09612033211062523. Epub 2021 Dec 16. Lupus. 2021. PMID: 34915764 Free PMC article.
55 results